iVascular

Merry Christmas from #iVascular! 🎄 We wish you a joyful and peaceful holiday season filled with warmth and happiness. Thank you for being part of our journey to innovate and enhance patients’ lives—we’re excited to keep moving forward together in the coming year.

Don’t miss the session: “What if rotablator loses the battle?” at #GulfPCR2024 📅 Date: Thursday, December 19, 2024 🕒 Time: 15:25 – 16:55 h 📍 Location: Case Corner 2   Discover how Naviscore, the new player in calcified lesions, is changing the game. Presented by Dr Jeroen Tahon, Interventional Cardiologist at Imelda Hospital. See you there!   #iVascular #Naviscore 

Join us in Dubai on December 18–19, 2024, for the GulfPCR-GIM—the premier event for interventional cardiovascular professionals in the Middle East! 📍Visit us at booth A04 and explore our innovative solutions. #GulfPCR2024 #iVascular #Innovation

The excellent outcomes of Luminor were presented at the first day of PVI. First the SOL-Japan trial by Dr Soga, that in 1 year follow-up just 1 patient needed reintervention. Later, TINTIN trial 5-year sugroup analysis by Dr. Deloose, demonstrated that the treatment with Luminor + iVolution pro is the perfect combination for complex and long lesions.

Looking forward to meeting you today at #PVI2024. Join us at booth No. 34 and check out our full scientific program, to learn more about our solutions for the treatment of vascular diseases. #endovascularintervention #PVI2024

Join us at the Paris Vascular Insights Course from December 12–14, 2024, in Paris, France! 🇫🇷 📍 Stop by our booth to discover our advanced peripheral portfolio and stay tuned for exciting updates on our scientific program. #PVI24 #iVascular #VascularInnovation

At iVascular, we are deeply committed to fostering social and workplace inclusion. We proudly collaborate with organizations and companies that help us create meaningful opportunities for a vulnerable group, such as: Taller Jeroni de Moragas - CET Fundació Privada Iris Refruiting Prodis Together, we can build a future that values diversity and inclusion in every aspect of life. #DisabilityDay #InclusionMatters #SocialImpact #WorkplaceDiversity

We are at the ASVS 2024! Today Dr Koen Deloose has presented the needs for a stent in the iliacs, introducing the new generation covered stent: iCover   Dr Uthaipaisanwong (King Chulangcorn Memorial Hospital) and Dr Mutirangura (Vajira Hospital) have presented some complex cases with iCover in iliacs and other uses #ASVS2024 #iVascular #VascularInnovation

iVascular has announced the initiation of Opal, the first-in-human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. Opal is a prospective, single-arm, multicentre study with a sample size of 70 patients requiring peripheral embolization. Sofía Valle https://lnkd.in/eiZxSjmd

A cutting-edge PCI workshop was recently held at Izola General Hospital, Slovenia, led by the esteemed Dr Jurij Avramovic Gregoric. The session focused on plaque modification techniques and advanced #DCB treatments, offering practical insights into treating complex lesions. 🌍 Participants from Ukraine, Bulgaria, Belgium, and Italy had the opportunity to witness challenging cases expertly managed with #Naviscore and #EssentialPro, showcasing their clinical value in real-world applications. At iVascular, we are committed to supporting the education and training of physicians worldwide, ensuring they have access to the latest techniques and technologies to enhance patient care. A special thanks to Dr Avramovic and our partner in Slovenia, Thomy FE, for their outstanding support and collaboration! 📌 Discover more about the innovative iVascular coronary portfolio: https://lnkd.in/e5NBCNfE #iVascular #PCI #InterventionalCardiology #Innovation #MedicalEducation